Executive Summary
Calix Limited provides industrial solutions to address global sustainability challenges in Australia and internationally. More Details
Rewards
Risk Analysis
Currently unprofitable and not forecast to become profitable over the next 3 years
Snowflake Analysis
Excellent balance sheet with limited growth.
Share Price & News
How has Calix's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CXL's share price has been volatile over the past 3 months.
Market Performance
7 Day Return
0.6%
CXL
-2.1%
AU Chemicals
-0.3%
AU Market
1 Year Return
12.6%
CXL
-33.9%
AU Chemicals
-6.9%
AU Market
Return vs Industry: CXL exceeded the Australian Chemicals industry which returned -33.9% over the past year.
Return vs Market: CXL exceeded the Australian Market which returned -6.9% over the past year.
Shareholder returns
| CXL | Industry | Market | |
|---|---|---|---|
| 7 Day | 0.6% | -2.1% | -0.3% |
| 30 Day | -13.4% | -2.3% | 3.7% |
| 90 Day | 0.6% | -2.5% | 3.8% |
| 1 Year | 12.6%12.6% | -32.9%-33.9% | -3.5%-6.9% |
| 3 Year | n/a | -30.7%-34.3% | 18.1%3.0% |
| 5 Year | n/a | -21.2%-29.8% | 44.2%15.1% |
Price Volatility Vs. Market
How volatile is Calix's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 months ago | Simply Wall St
Is Calix Limited (ASX:CXL) Trading At A 29% Discount?5 months ago | Simply Wall St
Calix (ASX:CXL) Shareholders Have Enjoyed A 11% Share Price Gain5 months ago | Simply Wall St
Could Calix Limited's (ASX:CXL) Investor Composition Influence The Stock Price?Valuation
Is Calix undervalued compared to its fair value and its price relative to the market?
4.52x
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: CXL (A$0.81) is trading above our estimate of fair value (A$0.21)
Significantly Below Fair Value: CXL is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: CXL is unprofitable, so we can't compare its PE Ratio to the AU Chemicals industry average.
PE vs Market: CXL is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CXL's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CXL is overvalued based on its PB Ratio (4.5x) compared to the AU Chemicals industry average (4.1x).
Next Steps
Future Growth
How is Calix forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
53.3%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CXL is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CXL is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CXL is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CXL's revenue (27.3% per year) is forecast to grow faster than the Australian market (4.6% per year).
High Growth Revenue: CXL's revenue (27.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CXL is forecast to be unprofitable in 3 years.
Next Steps
Past Performance
How has Calix performed over the past 5 years?
-25.7%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CXL is currently unprofitable.
Growing Profit Margin: CXL is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: CXL is unprofitable, and losses have increased over the past 5 years at a rate of 25.7% per year.
Accelerating Growth: Unable to compare CXL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CXL is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-3.9%).
Return on Equity
High ROE: CXL has a negative Return on Equity (-26.98%), as it is currently unprofitable.
Next Steps
Financial Health
How is Calix's financial position?
Financial Position Analysis
Short Term Liabilities: CXL's short term assets (A$19.4M) exceed its short term liabilities (A$15.5M).
Long Term Liabilities: CXL's short term assets (A$19.4M) exceed its long term liabilities (A$1.0M).
Debt to Equity History and Analysis
Debt Level: CXL's debt to equity ratio (0.9%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if CXL's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable CXL has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: CXL is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 28.7% per year.
Next Steps
Dividend
What is Calix current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CXL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CXL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CXL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CXL's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CXL's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
5.1yrs
Average management tenure
CEO
Phil Hodgson
7.75yrs
Tenure
AU$569,701
Compensation
Dr. Philip Hargraves Hodgson also known as Phil, BE, PhD has been Chief Executive Officer of Calix Limited since 2013 and serves as its Managing Director. He has been Director of Calix Limited since Februa ...
CEO Compensation Analysis
Compensation vs Market: Phil's total compensation ($USD405.16K) is above average for companies of similar size in the Australian market ($USD277.63K).
Compensation vs Earnings: Phil's compensation has increased whilst the company is unprofitable.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Director | 7.75yrs | AU$569.70k | 2.75% A$ 3.3m | |
| Co-Founder | 6.75yrs | AU$430.16k | 5.34% A$ 6.4m | |
| CFO & Company Secretary | 9.75yrs | AU$409.38k | 0.52% A$ 622.0k | |
| General Manager of Sales | 2.42yrs | AU$331.40k | 0.0097% A$ 11.7k | |
| General Manager of Strategy & Commercial | no data | AU$371.56k | 0.50% A$ 597.0k | |
| Operations Manager | 1.58yrs | no data | no data | |
| General Manager of Marketing | 1.5yrs | no data | no data |
5.1yrs
Average Tenure
Experienced Management: CXL's management team is seasoned and experienced (5.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Director | 7.75yrs | AU$569.70k | 2.75% A$ 3.3m | |
| Co-Founder | 6.75yrs | AU$430.16k | 5.34% A$ 6.4m | |
| Independent Non-Executive Director | 7.92yrs | AU$150.83k | 1.48% A$ 1.8m | |
| Independent Director | 6.67yrs | AU$85.34k | 0.093% A$ 111.8k | |
| Non-Executive Chairman | 7.75yrs | AU$210.00k | 0.76% A$ 908.8k | |
| Independent Non-Executive Director | 0.083yr | no data | no data |
6.7yrs
Average Tenure
64yo
Average Age
Experienced Board: CXL's board of directors are considered experienced (6.7 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.6%.
Top Shareholders
Company Information
Calix Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Calix Limited
- Ticker: CXL
- Exchange: ASX
- Founded: 2005
- Industry: Commodity Chemicals
- Sector: Materials
- Market Cap: AU$120.216m
- Shares outstanding: 148.41m
- Website: https://www.calix.global
Location
- Calix Limited
- 9-11 Bridge Street
- Level 1
- Sydney
- New South Wales
- 2073
- Australia
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| CXL | ASX (Australian Securities Exchange) | Yes | Ordinary Shares | AU | AUD | Jul 2018 |
| CXL | CHIA (Chi-X Australia) | Yes | Ordinary Shares | AU | AUD | Jul 2018 |
Biography
Calix Limited provides industrial solutions to address global sustainability challenges in Australia and internationally. The company offers ACTI-Mag, a solution for phosphate removal, pH and boost alkalin ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/10/26 10:42 |
| End of Day Share Price | 2020/10/26 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2020/06/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.